Opportunities with China during and post COVID-19 – a case study on Australian innovation addressing Post COVID-19 syndrome in China – An interview with Rob Phillips from Uscom.
China was one of the first countries that emerged from the COVID-19 crisis, continuing to post impressive economic growth in 2021. While China’s immediate response to the pandemic has been highly effective in controlling COVID-19, the pandemic has led to profound changes in China’s health care system.
Alison Choy Flannigan, Partner and Leader of Health Community at Hall & Wilcox, will be in conversation with Prof. Rob Phillips, Executive Chairman and CEO of Uscom Limited, to explore the challenges and opportunities in China after COVID-19, with a particular focus on Australian innovation in the health sector. Owen Zheng, Director of Morrison Innovations, will provide added commentary.
Uscom is an Australian Company which has received recognition from the Chinese Government, winning National High Tech awards in relation to its non-invasive cardiovascular and pulmonary technologies to treat post COVID-19 symptoms. Uscom has a mission to demonstrate leadership in science and create non-invasive devices that assist clinicians improve clinical care and patient outcomes. Uscom has three practice changing suites of devices in the field of cardiac, vascular and pulmonary monitoring; the USCOM 1A advanced hemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic Suite of digital multi-path ultrasonic spirometers.
Date: Wednesday, 28 July 2021
Time: 12-1pm AEST
Alison Choy Flannigan, Partner & Leader, Health & Community, Hall & Wilcox
With over 25 years of corporate, commercial and regulatory experience, Alison has specialised in advising clients in the health, aged care, disability, life sciences and community sectors. Alison leads the firm’s Health & Community industry group. She is the Company Secretary for the National Foundation for Medical Research and Innovation. Alison is Publication and Newsletter Officer, Healthcare and Life Sciences Committee, International Bar Association. She is also on the Australia Chinese Business Council (NSW) Health & Ageing Subcommittee.
Prof. Rob Phillips, Executive Chairman and CEO, Uscom Limited
Rob Phillips is the inventor and founder of Uscom Limited and took the Company to public listing in 2003. Rob has more than 15yrs experience as Chairman and CEO of an ASX listed Medical Technology Company. Rob has successfully engineered the acquisition and integration of two international medical device companies and brought these new products to international markets by establishing a global web of Uscom subsidiaries and distribution channels. Associate Professor Rob Phillips has a Doctor of Philosophy and a Master of Philosophy from the School of Medicine at The University of Queensland, Australia. Rob conceived and developed the USCOM 1A device and is the author of over 40 patents in cardiovascular monitoring and ultrasound, and has spent over 20 years collaborating, teaching and lecturing in China.
Owen Zheng, Director, Morrison Innovations
Owen is an entrepreneur, venture capitalist and project manager. Prior to his current role with Morrison Innovations, Owen has worked for New York and Hong Kong dual-listed medical device manufacturers as well as Australian private and public healthcare providers. Inspired by Australia’s exceptional R&D capacity, Owen co-founded Morrison Innovations in 2017. In early 2020, Owen successfully attracted private investment to establish HygiMed Australia, a company specialising in an innovative range of medical consumables and personal protective equipment (PPE). Owen is now working with the MedTech community to bring more innovative technologies and devices into the market via a strengthened domestic and global supply chain.